Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

Market Cap	23.26B
Revenue (ttm)	6.73B
Net Income (ttm)	1.92B
Shares Out	920.66M
EPS (ttm)	2.08
PE Ratio	12.12
Forward PE	10.79
Dividend	2.09 (8.27%)
Ex-Dividend Date	Jun 30, 2025

Volume	4,812,558
Average Volume	4,201,773
Open	25.48
Previous Close	25.39
Day's Range	25.23 - 25.85
52-Week Range	24.20 - 33.08
Beta	0.04
RSI	47.69
Earnings Date	Oct 23, 2025

About SHA:600566

Hubei Jumpcan Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, and trading of Chinese traditional medicines, western medicines, daily use chemical based Chinese traditional medicines, and Chinese medicine health products in China. The company offers Chinese and western medicines in the areas of pediatrics, gynecology, pneumology, gastroenterology, neurology, and geriatrics; oral and skin care products; and anti-fatigue, anti-aging, antioxidant, and immunity-enhancing Chinese medicine health products. It also develop...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• CEO: Fei Cao
• Employees: 5,026
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600566

Financial Performance

In 2024, SHA:600566's revenue was 8.02 billion, a decrease of -16.96% compared to the previous year's 9.65 billion. Earnings were 2.53 billion, a decrease of -10.32%.